Total Payments
$26,134
2024 Payments
$5,512
Companies
43
Transactions
325
Medicare Patients
9,471
Medicare Billing
$2.5M
Payment Breakdown by Category
Food & Beverage$9,561 (36.6%)
Consulting$9,080 (34.7%)
Other$7,350 (28.1%)
Education$132.82 (0.5%)
Gifts$9.72 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,561 | 312 | 36.6% |
| Consulting Fee | $9,080 | 5 | 34.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $7,350 | 5 | 28.1% |
| Education | $132.82 | 2 | 0.5% |
| Gift | $9.72 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Eisai Inc. | $17,744 | 39 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,623 | 63 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,018 | 33 | $0 (2024) |
| INTUITIVE SURGICAL, INC. | $757.80 | 15 | $0 (2024) |
| Seagen Inc. | $702.14 | 30 | $0 (2023) |
| Tempus AI, Inc | $585.54 | 20 | $0 (2024) |
| Merck Sharp & Dohme LLC | $530.65 | 22 | $0 (2024) |
| PFIZER INC. | $349.39 | 17 | $0 (2024) |
| ABBVIE INC. | $280.62 | 11 | $0 (2023) |
| Biom'Up France SAS | $238.37 | 3 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $5,512 | 76 | Eisai Inc. ($3,524) |
| 2023 | $5,555 | 58 | Eisai Inc. ($4,335) |
| 2022 | $7,532 | 58 | EISAI INC. ($6,163) |
| 2021 | $4,446 | 25 | Eisai Inc. ($3,626) |
| 2020 | $128.46 | 7 | AstraZeneca Pharmaceuticals LP ($54.31) |
| 2019 | $883.69 | 32 | AstraZeneca Pharmaceuticals LP ($222.83) |
| 2018 | $986.16 | 30 | Intuitive Surgical, Inc. ($253.01) |
| 2017 | $1,090 | 39 | Intuitive Surgical, Inc. ($205.71) |
All Payment Transactions
325 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | PFIZER INC. | TIVDAK (Biological) | Food and Beverage | In-kind items and services | $25.40 | General |
| Category: Oncology | ||||||
| 12/11/2024 | Eisai Inc. | — | Food and Beverage | In-kind items and services | $119.51 | General |
| 12/05/2024 | Merck Sharp & Dohme LLC | LYNPARZA (Biological) | Food and Beverage | In-kind items and services | $20.53 | General |
| Category: ONCOLOGY | ||||||
| 12/04/2024 | GlaxoSmithKline, LLC. | JEMPERLI (Biological), ZEJULA | Food and Beverage | In-kind items and services | $26.92 | General |
| Category: ONCOLOGY | ||||||
| 11/15/2024 | Tempus AI, Inc | XT CDX (Device) | Food and Beverage | In-kind items and services | $23.74 | General |
| Category: NONE | ||||||
| 11/15/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $3.82 | General |
| Category: Oncology | ||||||
| 11/14/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $23.77 | General |
| Category: Oncology | ||||||
| 11/13/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $24.15 | General |
| Category: Oncology | ||||||
| 11/07/2024 | Tempus AI, Inc | XT CDX (Device) | Food and Beverage | In-kind items and services | $28.16 | General |
| Category: NONE | ||||||
| 11/07/2024 | PFIZER INC. | TIVDAK (Biological) | Food and Beverage | In-kind items and services | $24.40 | General |
| Category: Oncology | ||||||
| 11/06/2024 | GlaxoSmithKline, LLC. | JEMPERLI (Biological), ZEJULA | Food and Beverage | In-kind items and services | $24.21 | General |
| Category: ONCOLOGY | ||||||
| 10/29/2024 | CONMED Corporation | AIRSEAL (Device) | Food and Beverage | In-kind items and services | $34.28 | General |
| Category: GENERAL SURGERY | ||||||
| 10/23/2024 | Tempus AI, Inc | XT CDX (Device) | Food and Beverage | In-kind items and services | $24.89 | General |
| Category: NONE | ||||||
| 10/23/2024 | Tempus AI, Inc | XT CDX (Device) | Food and Beverage | In-kind items and services | $24.69 | General |
| Category: NONE | ||||||
| 10/17/2024 | Merck Sharp & Dohme LLC | LYNPARZA (Biological) | Food and Beverage | In-kind items and services | $22.24 | General |
| Category: ONCOLOGY | ||||||
| 10/16/2024 | GlaxoSmithKline, LLC. | JEMPERLI (Biological) | Food and Beverage | In-kind items and services | $124.46 | General |
| Category: ONCOLOGY | ||||||
| 10/16/2024 | CooperSurgical, Inc. | Advincula Delineator Uterine Manipulator (Device) | Food and Beverage | In-kind items and services | $15.31 | General |
| Category: Devices | ||||||
| 10/09/2024 | PFIZER INC. | TIVDAK (Biological) | Food and Beverage | In-kind items and services | $25.40 | General |
| Category: Oncology | ||||||
| 10/02/2024 | GlaxoSmithKline, LLC. | JEMPERLI (Biological), ZEJULA | Food and Beverage | In-kind items and services | $25.58 | General |
| Category: ONCOLOGY | ||||||
| 09/18/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $22.02 | General |
| Category: Oncology | ||||||
| 09/17/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Food and Beverage | In-kind items and services | $123.66 | General |
| Category: SURGERY | ||||||
| 09/12/2024 | Tempus AI, Inc | XT CDX (Device) | Food and Beverage | In-kind items and services | $134.96 | General |
| Category: NONE | ||||||
| 09/12/2024 | PFIZER INC. | TIVDAK (Biological) | Food and Beverage | In-kind items and services | $23.24 | General |
| Category: Oncology | ||||||
| 09/12/2024 | PFIZER INC. | TIVDAK (Biological) | Food and Beverage | In-kind items and services | $2.38 | General |
| Category: Oncology | ||||||
| 09/05/2024 | Tempus AI, Inc | XT CDX (Device) | Food and Beverage | In-kind items and services | $26.39 | General |
| Category: NONE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 37 | 2,073 | 26,169 | $2.0M | $456,416 |
| 2022 | 45 | 2,327 | 48,716 | $2.6M | $648,875 |
| 2021 | 49 | 2,575 | 57,445 | $2.4M | $639,138 |
| 2020 | 47 | 2,496 | 64,805 | $2.6M | $804,569 |
Total Patients
9,471
Total Services
197,135
Medicare Billing
$2.5M
Procedure Codes
178
All Medicare Procedures & Services
178 procedure records from CMS Medicare Utilization — Page 1 of 8
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 496 | 1,071 | $406,980 | $104,047 | 25.6% |
| J2506 | Injection, pegfilgrastim, excludes biosimilar, 0.5 mg | Office | 2023 | 16 | 828 | $331,200 | $73,005 | 22.0% |
| 50715 | Release of scar tissue at ureter | Facility | 2023 | 50 | 50 | $210,000 | $60,395 | 28.8% |
| 58548 | Removal of uterus, cervix, and lymph nodes of pelvis with biopsy of aortic lymph node using an endoscope | Facility | 2023 | 16 | 16 | $96,000 | $26,149 | 27.2% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 27 | 184 | $80,960 | $19,597 | 24.2% |
| 58558 | Biopsy of lining of uterus and/or removal of polyp using an endoscope | Office | 2023 | 17 | 17 | $34,000 | $18,859 | 55.5% |
| 57423 | Repair of vaginal defect using an endoscope | Facility | 2023 | 42 | 42 | $151,200 | $16,953 | 11.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 104 | 104 | $53,664 | $13,578 | 25.3% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2023 | 269 | 269 | $38,198 | $11,871 | 31.1% |
| 57420 | Exam of vagina and cervix using an endoscope | Office | 2023 | 88 | 108 | $41,327 | $11,613 | 28.1% |
| 57452 | Exam of cervix and upper part of vagina using an endoscope | Office | 2023 | 84 | 105 | $38,010 | $10,870 | 28.6% |
| 76830 | Ultrasound scan of uterus, ovaries, tubes, cervix and pelvic area through vagina | Office | 2023 | 95 | 111 | $45,177 | $10,810 | 23.9% |
| 56820 | Exam of external female genitals using an endoscope | Office | 2023 | 67 | 105 | $50,400 | $10,782 | 21.4% |
| 58573 | Removal of uterus, tubes, and/or ovaries through abdomen using an endoscope, more than 250.0 g | Facility | 2023 | 19 | 19 | $98,800 | $9,884 | 10.0% |
| 49204 | Removal or destruction of cysts or growths of abdominal cavity, 5.1 to 10.0 cm | Facility | 2023 | 13 | 13 | $65,000 | $8,767 | 13.5% |
| 96415 | Administration of chemotherapy into vein, each additional hour | Office | 2023 | 22 | 293 | $32,230 | $6,780 | 21.0% |
| 96417 | Administration of additional new drug or substance into vein, 1 hour or less | Office | 2023 | 21 | 120 | $24,000 | $6,330 | 26.4% |
| 96367 | Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | Office | 2023 | 23 | 247 | $19,760 | $5,795 | 29.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 153 | 619 | $15,475 | $5,200 | 33.6% |
| 76856 | Complete ultrasound scan of pelvis | Office | 2023 | 39 | 42 | $16,926 | $3,592 | 21.2% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 44 | 446 | $9,590 | $3,394 | 35.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 13 | 20 | $11,600 | $2,744 | 23.7% |
| 96375 | Injection of additional new drug or substance into vein | Office | 2023 | 23 | 181 | $13,032 | $2,289 | 17.6% |
| 96368 | Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion | Office | 2023 | 23 | 127 | $11,684 | $2,054 | 17.6% |
| 56821 | Exam and biopsy of external female genitals using an endoscope | Office | 2023 | 12 | 13 | $7,360 | $1,800 | 24.5% |
About Dr. Fernando Recio, MD
Dr. Fernando Recio, MD is a Hematology & Oncology healthcare provider based in Boca Raton, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/29/2005. The National Provider Identifier (NPI) number assigned to this provider is 1245227818.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Fernando Recio, MD has received a total of $26,134 in payments from pharmaceutical and medical device companies, with $5,512 received in 2024. These payments were reported across 325 transactions from 43 companies. The most common payment nature is "Food and Beverage" ($9,561).
As a Medicare-enrolled provider, Recio has provided services to 9,471 Medicare beneficiaries, totaling 197,135 services with total Medicare billing of $2.5M. Data is available for 4 years (2020–2023), covering 178 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Location Boca Raton, FL
- Active Since 09/29/2005
- Last Updated 12/06/2010
- Taxonomy Code 207RH0003X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1245227818
Products in Payments
- Lenvima (Drug) $17,310
- LYNPARZA (Drug) $1,601
- TIVDAK (Biological) $850.00
- Da Vinci Surgical System (Device) $757.80
- JEMPERLI (Biological) $664.34
- XT CDX (Device) $585.54
- ZEJULA (Drug) $456.22
- KEYTRUDA (Biological) $297.66
- HEMOBLAST BELLOWS (Device) $238.37
- LYNPARZA (Biological) $232.99
- Caiman Vessel Sealers (Device) $185.41
- Orilissa (Drug) $160.00
- Uterine Manipulators & Injectors (Device) $136.93
- EIKON LT ADAPT (Device) $125.42
- PREVELEAK (Device) $116.16
- BIOFIX (Device) $110.42
- myChoice CDx (Device) $97.34
- MYFEMBREE (Drug) $89.06
- PROVENGE (Drug) $87.59
- Vitrakvi (Drug) $83.55
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Boca Raton
Mohammad Jahanzeb, Md, MD
Hematology & Oncology — Payments: $1.3M
Hematology & Oncology $1.3M
Dr. Liat Dagan, Md, MD
Hematology & Oncology — Payments: $9,194
Hematology & Oncology $9,194
Dr. Paul Hyman, Md, MD
Hematology & Oncology — Payments: $9,103
Hematology & Oncology $9,103
Dr. Bachir Berbari, Md, MD
Hematology & Oncology — Payments: $6,995
Hematology & Oncology $6,995
Dr. Steven Morris, M.d, M.D
Hematology & Oncology — Payments: $6,937
Hematology & Oncology $6,937
Dr. Aurea Tomeski, M.d, M.D
Hematology & Oncology — Payments: $22.15
Hematology & Oncology $22.15